Your browser doesn't support javascript.
loading
Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/ß-endorphin pathway.
Jia, Yu; Gong, Nian; Li, Teng-Fei; Zhu, Bin; Wang, Yong-Xiang.
Afiliación
  • Jia Y; King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, China.
  • Gong N; King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, China.
  • Li TF; King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, China.
  • Zhu B; King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, China.
  • Wang YX; King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, China. Electronic address: yxwang@sjtu.edu.cn.
Pharmacol Res ; 102: 276-85, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26546042
ABSTRACT
Both peptidic agonist exenatide and herbal agonist catalpol of the glucagon-like peptide-1 receptor (GLP-1R) are neuroprotective. We have previously shown that activation of spinal GLP-1Rs expresses ß-endorphin in microglia to produce antinociception. The aim of this study was to explore whether exenatide and catalpol exert neuroprotection via activation of the hippocampal GLP-1R/ß-endorphin pathway. The rat middle cerebral artery occlusion model was employed, and the GLP-1R immunofluorescence staining and ß-endorphin measurement were assayed in the hippocampus and primary cultures of microglia, neurons and astrocytes. The immunoreactivity of GLP-1Rs on microglia in the hippocampus was upregulated after ischemia reperfusion. Intracerebroventricular (i.c.v.) injection of exenatide and catalpol produced neuroprotection in the rat transient ischemia/reperfusion model, reflected by a marked reduction in brain infarction size and a mild recovery in neurobehavioral deficits. In addition, i.c.v. injection of exenatide and catalpol significantly stimulated ß-endorphin expression in the hippocampus and cultured primary microglia (but not primary neurons or astrocytes). Furthermore, exenatide and catalpol neuroprotection was completely blocked by i.c.v. injection of the GLP-1R orthosteric antagonist exendin (9-39), specific ß-endorphin antiserum, and selective opioid receptor antagonist naloxone. Our results indicate, for the first time, that the neuroprotective effects of catalpol and exenatide are GLP-1R-specific, and that these effects are mediated by ß-endorphin expression probably in hippocampal microglia. We postulate that in contrast to the peripheral tissue, where the activation of GLP-1Rs in pancreas islet ß-cells causes secretion of insulin to perform glucoregulation, it leads to ß-endorphin expression in microglial cells to produce neuroprotection and analgesia in the central nervous system.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptidos / Ponzoñas / Betaendorfina / Fármacos Neuroprotectores / Glucósidos Iridoides / Receptor del Péptido 1 Similar al Glucagón / Neuroprotección / Hipocampo Límite: Animals Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptidos / Ponzoñas / Betaendorfina / Fármacos Neuroprotectores / Glucósidos Iridoides / Receptor del Péptido 1 Similar al Glucagón / Neuroprotección / Hipocampo Límite: Animals Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: China